Cargando…

Toll-like receptor 1 as a possible target in non-alcoholic fatty liver disease

Toll-like receptors (TLRs) in the liver compartment have repeatedly been attributed to the development of non-alcoholic fatty liver disease (NAFLD). Knowledge on TLR expression in blood cells and their relation to intestinal microbiota and NAFLD development is limited. Here, we determined TLR expres...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baumann, Anja, Nier, Anika, Hernández-Arriaga, Angélica, Brandt, Annette, Lorenzo Pisarello, Maria J., Jin, Cheng J., Pilar, Esther, Camarinha-Silva, Amélia, Schattenberg, Jörn M., Bergheim, Ina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426394/ https://www.ncbi.nlm.nih.gov/pubmed/34497333 http://dx.doi.org/10.1038/s41598-021-97346-9

Ejemplares similares

Metformin attenuates the onset of non-alcoholic fatty liver disease and affects intestinal microbiota and barrier in small intestine
por: Brandt, Annette, et al.
Publicado: (2019)

Citrulline supplementation attenuates the development of non-alcoholic steatohepatitis in female mice through mechanisms involving intestinal arginase
por: Rajcic, Dragana, et al.
Publicado: (2021)

Adipokines and Endotoxemia Correlate with Hepatic Steatosis in Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Nier, Anika, et al.
Publicado: (2020)

Non-Alcoholic Fatty Liver Disease in Overweight Children: Role of Fructose Intake and Dietary Pattern
por: Nier, Anika, et al.
Publicado: (2018)

Cognitive Alterations in Old Mice Are Associated with Intestinal Barrier Dysfunction and Induced Toll-like Receptor 2 and 4 Signaling in Different Brain Regions
por: Brandt, Annette, et al.
Publicado: (2023)

Supplementing L-Citrulline Can Extend Lifespan in C. elegans and Attenuate the Development of Aging-Related Impairments of Glucose Tolerance and Intestinal Barrier in Mice
por: Rajcic, Dragana, et al.
Publicado: (2023)

Metabolic Abnormalities in Normal Weight Children Are Associated with Increased Visceral Fat Accumulation, Elevated Plasma Endotoxin Levels and a Higher Monosaccharide Intake
por: Nier, Anika, et al.
Publicado: (2019)

Alterations of nitric oxide homeostasis as trigger of intestinal barrier dysfunction in non‐alcoholic fatty liver disease
por: Baumann, Anja, et al.
Publicado: (2022)

Impairments of intestinal arginine and NO metabolisms trigger aging-associated intestinal barrier dysfunction and ‘inflammaging'
por: Brandt, Annette, et al.
Publicado: (2022)

Exchanging dietary fat source with extra virgin olive oil does not prevent progression of diet-induced non-alcoholic fatty liver disease and insulin resistance
por: Rajcic, Dragana, et al.
Publicado: (2020)

Oral Supplementation of Sodium Butyrate Attenuates the Progression of Non-Alcoholic Steatohepatitis
por: Baumann, Anja, et al.
Publicado: (2020)

Nutritional Intake and the Risk for Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Schattenberg, Jörn M., et al.
Publicado: (2019)

Changes in Oral Microbial Ecology of C57BL/6 Mice at Different Ages Associated with Sampling Methodology
por: Hernández-Arriaga, Angélica, et al.
Publicado: (2019)

Markers of intestinal permeability are already altered in early stages of non-alcoholic fatty liver disease: Studies in children
por: Nier, Anika, et al.
Publicado: (2017)

Fortifying Butterfat with Soybean Oil Attenuates the Onset of Diet-Induced Non-Alcoholic Steatohepatitis and Glucose Intolerance
por: Sánchez, Victor, et al.
Publicado: (2021)

Short‐Term Isocaloric Intake of a Fructose‐ but not Glucose‐Rich Diet Affects Bacterial Endotoxin Concentrations and Markers of Metabolic Health in Normal Weight Healthy Subjects
por: Nier, Anika, et al.
Publicado: (2019)

Consumption of decaffeinated coffee protects against the development of early non-alcoholic steatohepatitis: Role of intestinal barrier function
por: Brandt, Annette, et al.
Publicado: (2018)

Beneficial Effects of Vitamin D Treatment in an Obese Mouse Model of Non-Alcoholic Steatohepatitis
por: Jahn, Daniel, et al.
Publicado: (2019)

TNFα is a key trigger of inflammation in diet-induced non-obese MASLD in mice
por: Burger, Katharina, et al.
Publicado: (2023)

In Vitro and in Vivo Models of Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Kanuri, Giridhar, et al.
Publicado: (2013)

Oral arginine supplementation protects female mice from the onset of non-alcoholic steatohepatitis
por: Sellmann, Cathrin, et al.
Publicado: (2017)

Markers of Intestinal Permeability Are Rapidly Improved by Alcohol Withdrawal in Patients with Alcohol-Related Liver Disease
por: Jung, Finn, et al.
Publicado: (2021)

Fructose: a modulator of intestinal barrier function and hepatic health?
por: Staltner, Raphaela, et al.
Publicado: (2023)

Acute Intake of Sucrose but Not of the Intense Sweetener Sucralose Is Associated with Post-Prandial Endotoxemia in Healthy Young Adults—A Randomized Controlled Trial
por: Staltner, Raphaela, et al.
Publicado: (2023)

The Intestinal Barrier Dysfunction as Driving Factor of Inflammaging
por: Untersmayr, Eva, et al.
Publicado: (2022)

Assessing the disease burden of non-alcoholic fatty liver disease in the real world – big data and big numbers
por: Schattenberg, Jörn M., et al.
Publicado: (2019)

Beyond the Paradigm of Weight Loss in Non-Alcoholic Fatty Liver Disease: From Pathophysiology to Novel Dietary Approaches
por: Armandi, Angelo, et al.
Publicado: (2021)

Effects on the Ileal Microbiota of Phosphorus and Calcium Utilization, Bird Performance, and Gender in Japanese Quail
por: Borda-Molina, Daniel, et al.
Publicado: (2020)

“Get the best out of what comes in” – adaptation of the microbiota of chamois (Rupicapra rupicapra) to seasonal forage availability in the Bavarian Alps
por: Dahl, Sarah-Alica, et al.
Publicado: (2023)

Moderate consumption of fermented alcoholic beverages diminishes diet-induced non-alcoholic fatty liver disease through mechanisms involving hepatic adiponectin signaling in mice
por: Jung, Finn, et al.
Publicado: (2019)

Impact of thyroid disorders on the incidence of non‐alcoholic fatty liver disease in Germany
por: Labenz, Christian, et al.
Publicado: (2021)

Lactobacillus rhamnosus GG Protects against Non-Alcoholic Fatty Liver Disease in Mice
por: Ritze, Yvonne, et al.
Publicado: (2014)

The Snoring Index Identifies Risk of Non-Alcoholic Fatty Liver Disease in Patients with Obstructive Sleep Apnea Syndrome
por: Bahr, Katharina, et al.
Publicado: (2021)

A Xanthohumol-Rich Hop Extract Diminishes Endotoxin-Induced Activation of TLR4 Signaling in Human Peripheral Blood Mononuclear Cells: A Study in Healthy Women
por: Jung, Finn, et al.
Publicado: (2022)

Short-Term Intake of a Fructose-, Fat- and Cholesterol-Rich Diet Causes Hepatic Steatosis in Mice: Effect of Antibiotic Treatment
por: Brandt, Annette, et al.
Publicado: (2017)

Oral intake of xanthohumol attenuates lipoteichoic acid-induced inflammatory response in human PBMCs
por: Jung, Finn, et al.
Publicado: (2022)

Referral care paths for non‐alcoholic fatty liver disease—Gearing up for an ever more prevalent and severe liver disease
por: van Dijk, Anne‐Marieke, et al.
Publicado: (2021)

Microbiota and Nutrient Portraits of European Roe Deer (Capreolus capreolus) Rumen Contents in Characteristic Southern German Habitats
por: Dahl, Sarah-Alica, et al.
Publicado: (2023)

Web-Based Exercise as an Effective Complementary Treatment for Patients With Nonalcoholic Fatty Liver Disease: Intervention Study
por: Pfirrmann, Daniel, et al.
Publicado: (2019)

Incident Dementia in Elderly Patients with Nonalcoholic Fatty Liver Disease in Germany
por: Labenz, Christian, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_cp0oi02nbostso9q7hpn843cm1